Evidence map›Paper›PMID 19417216›Full record

ArticleScience signaling2009

Complexity in transcription control at the activation domain-mediator interface.

Michael A Balamotis, Mario A Pennella, Jennitte L Stevens, Bohdan Wasylyk, Andrew S Belmont, Arnold J Berk

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Science signaling, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 84 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Journal of medicine and life · 2024
    Article
  6. Genetically Engineered Mice Unveil In Vivo Roles of the Mediator Complex.International journal of molecular sciences · 2023
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Michael A BalamotisDepartment of Microbiology, Immunology and Molecular Genetics, Molecular Biology Institute, University of California-Los Angeles, Los Angeles, CA 90095, USA.
Mario A Pennella
Jennitte L Stevens
Bohdan Wasylyk
Andrew S Belmont
Arnold J Berk
University of California, Los Angeles · USAmgen (United States) · USInstitut de génétique et de biologie moléculaire et cellulaire · FRUniversity of Illinois Urbana-Champaign · US

Funding

BIOSYNTHESIS OF ADENOVIRUS EARLY RNASR37CA025235 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BERK, ARNOLD J · 1987 to 2011
$7.8M
LARGE SCALE CHROMATIN STRUCTURE/FUNCTIONR01GM042516 · NIGMS · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI BELMONT, ANDREW STEVEN · 1995 to 2007
$1.9M
NCI NIH HHS R37 CA025235NIGMS NIH HHS R01 GM042516
6 · The paper itself

Abstract

Transcript elongation by polymerase II paused at the Egr1 promoter is activated by mitogen-activated protein kinase phosphorylation of the ternary complex factor (TCF) ELK1 bound at multiple upstream sites and subsequent phospho-ELK1 interaction with mediator through the MED23 subunit. Consequently, Med23 knockout (KO) nearly eliminates Egr1 (early growth response factor 1) transcription in embryonic stem (ES) cells, leaving a paused polymerase at the promoter. Med23 KO did not, however, eliminate Egr1 transcription in fibroblasts. Chromatin immunoprecipitation analysis and direct visualization of fluorescently labeled TCF derivatives and mediator subunits revealed that three closely related TCFs bound to the same control regions. The relative amounts of these TCFs, which responded differently to the loss of MED23, differed in ES cells and fibroblasts. Transcriptome analysis suggests that most genes expressed in both cell types, such as Egr1, are regulated by alternative transcription factors in the two cell types that respond differently to the same signal transduction pathways.

Indexed as

Transcription, GeneticAdaptor Proteins, Signal TransducingAmino Acid SequenceAnimalsBinding SitesCell LineChromatin ImmunoprecipitationEarly Growth Response Protein 1Embryonic Stem CellsFibroblastsGene Expression ProfilingGene Expression RegulationLuminescent ProteinsMediator ComplexMiceMice, KnockoutAdaptor Proteins, Signal TransducingEarly Growth Response Protein 1Egr1 protein, mouseLuminescent ProteinsMed23 protein, mouseMediator ComplexRecombinant Fusion ProteinsRNA, MessengerRNA Polymerase IITernary Complex FactorsTrans-Activators

Identifiers

PMID19417216
PMCPMC2774526
OpenAlexW2091785290

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.